FDA Approved: LATISSE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LATISSE (bimatoprost) by Allergan, Inc., related to eyelash growth labeling/indication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotrichosis of Eyelashes

Drugs mentioned

• LATISSE (BIMATOPROST)

Snippet

SUPPL AP for LATISSE (BIMATOPROST)